Cannabis use and mental health-related quality of life among individuals with anxiety disorders

Journal of Anxiety Disorders

Volumn 26, Issue 8, 2012, Pages 799-810

  Lev Ran, Shaul ^a   Le Foll, Bernard ^a,b,c   McKenzie, Kwame ^a,b   Rehm, Jürgen ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anxiety; Cannabis; Mental health; Quality of life

Indexed keywords

CANNABIS;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CANNABIS ADDICTION; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; EMOTION; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOOD DISORDER; QUALITY OF LIFE; SAMPLE SIZE; SCORING SYSTEM; SHORT FORM 12; UNITED STATES;

ADULT; ANXIETY DISORDERS; COMORBIDITY; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MENTAL HEALTH; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE;

EID: 84866536260     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2012.07.002     Document Type: Article

References (66)

1. Agosti V., Nunes E., Levin F. Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence. The American Journal of Drug and Alcohol Abuse 2002, 28(4):643-652.
2. Agrawal A., Lynskey M.T., Pergadia M.L., Bucholz K.K., Heath A.C., Martin N.G., et al. Early cannabis use and DSM-IV nicotine dependence: a twin study. Addiction 2008, 103(11):1896-1904.
3. Ameringer K.J., Leventhal A.M. Applying the tripartite model of anxiety and depression to cigarette smoking: an integrative review. Nicotine & Tobacco Research 2010, 12(12):1183-1194.
4. Braida D., Limonta V., Malabarba L., Zani A., Sala M. 5-HT1A receptors are involved in the anxiolytic effect of Delta9-tetrahydrocannabinol and AM 404, the anandamide transport inhibitor, in Sprague-Dawley rats. European Journal of Pharmacology 2007, 555(2-3):156-163.
5. Bricker J.B., Russo J., Stein M.B., Sherbourne C., Craske M., Schraufnagel T.J., et al. Does occasional cannabis use impact anxiety and depression treatment outcomes? Results from a randomized effectiveness trial. Depression and Anxiety 2007, 24(6):392-398.
6. Buckner J.D., Heimberg R.G., Schneier F.R., Liu S.M., Wang S., Blanco C. The relationship between cannabis use disorders and social anxiety disorder in the National Epidemiological Study of Alcohol and Related Conditions (NESARC). Drug and Alcohol Dependence 2012, 124(1-2):128-134.
7. Chabrol H., Duconge E., Casas C., Roura C., Carey K.B. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addictive Behaviors 2005, 30(4):829-840.
8. Chatterji S., Saunders J.B., Vrasti R., Grant B.F., Hasin D., Mager D. Reliability of the alcohol and drug modules of the Alcohol Use Disorder and Associated Disabilities Interview Schedule - Alcohol/Drug-Revised (AUDADIS-ADR): an international comparison. Drug and Alcohol Dependence 1997, 47(3):171-185.
9. Cheung J.T., Mann R.E., Ialomiteanu A., Stoduto G., Chan V., Ala-Leppilampi K., et al. Anxiety and mood disorders and cannabis use. The American Journal of Drug and Alcohol Abuse 2010, 36(2):118-122.
10. Comer J.S., Blanco C., Hasin D.S., Liu S.M., Grant B.F., Turner J.B., et al. Health-related quality of life across the anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry 2011, 72(1):43-50.
11. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. Journal of the American Medical Association 2004, 291(17):2114-2121.
12. Cottler L.B., Grant B.F., Blaine J., Mavreas V., Pull C., Hasin D., et al. Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. Drug and Alcohol Dependence 1997, 47(3):195-205.
13. Crippa J.A., Zuardi A.W., Martin-Santos R., Bhattacharyya S., Atakan Z., McGuire P., et al. Cannabis and anxiety: a critical review of the evidence. Human Psychopharmacology: Clinical and Experimental 2009, 24(7):515-523.
14. Degenhardt L., Chiu W.T., Sampson N., Kessler R.C., Anthony J.C. Epidemiological patterns of extra-medical drug use in the United States: evidence from the National Comorbidity Survey Replication, 2001-2003. Drug and Alcohol Dependence 2007, 90(2-3):210-223.
15. Degenhardt L., Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012, 379(9810):55-70.
16. Dorard G., Berthoz S., Phan O., Corcos M., Bungener C. Affect dysregulation in cannabis abusers: a study in adolescents and young adults. European Child and Adolescent Psychiatry 2008, 17(5):274-282.
17. Fattore L., Fratta W. How important are sex differences in cannabinoid action. British Journal of Pharmacology 2010, 160(3):544-548.
18. Fazel S., Bains P., Doll H. Substance abuse and dependence in prisoners: a systematic review. Addiction 2006, 101(2):181-191.
19. Feeney G.F., Connor J.P., Young R.M., Tucker J., McPherson A. Cannabis dependence and mental health perception amongst people diverted by police after arrest for cannabis-related offending behaviour in Australia. Criminal Behaviour and Mental Health 2005, 15(4):249-260.
20. Fergusson D.M., Boden J.M. Cannabis use and later life outcomes. Addiction 2008, 103(6):969-976. (discussion 977-968).
21. Fergusson D.M., Horwood L., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002, 97(9):1123-1135.
22. Fergusson D.M., Horwood L.J. Early onset cannabis use and psychosocial adjustment in young adults. Addiction 1997, 92(3):279-296.
23. Gonzalez-Saiz F., Rojas O.L., Castillo I.I. Measuring the impact of psychoactive substance on health-related quality of life: an update. Current Drug Abuse Reviews 2009, 2(1):5-10.
24. Grant B.F., Dawson D.A., Stinson F.S., Chou P.S., Kay W., Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug and Alcohol Dependence 2003, 71(1):7-16.
25. Grant B.F., Hasin D. The Alcohol Use Disorder and Associated Disabilites Schedule - DSM-IV Version 2001, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
26. Grant B.F., Moore T.C., Kaplan K. Source and accuracy statement: Wave 1 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) 2003, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
27. Grant B.F., Pickering R. The relationship between cannabis use and DSM-IV cannabis abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse 1998, 10(3):255-264.
28. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry 2004, 61(8):807-816.
29. Grant J.D., Scherrer J.F., Neuman R.J., Todorov A.A., Price R.K., Bucholz K.K. A comparison of the latent class structure of cannabis problems among adult men and women who have used cannabis repeatedly. Addiction 2006, 101(8):1133-1142.
30. Greenberg P.E., Sisitsky T., Kessler R.C., Finkelstein S.N., Berndt E.R., Davidson J.R., et al. The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry 1999, 60(7):427-435.
31. Grucza R.A., Abbacchi A.M., Przybeck T.R., Gfroerer J.C. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys. Addiction 2007, 102(4):623-629.
32. Hall W., Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009, 374(9698):1383-1391.
33. Huang B., Grant B.F., Dawson D.A., Stinson F.S., Chou S.P., Saha T.D., et al. Race-ethnicity and the prevalence and co-occurrence of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, alcohol and drug use disorders and Axis I and II disorders: United States, 2001 to 2002. Comprehensive Psychiatry 2006, 47(4):252-257.
34. Kessler R.C., Chiu W.T., Demler O., Merikangas K.R., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 2005, 62(6):617-627.
35. Kessler R.C., Nelson C.B., McGonagle K.A., Edlund M.J., Frank R.G., Leaf P.J. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. American Journal of Orthopsychiatry 1996, 66(1):17-31.
36. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harvard Review of Psychiatry 1997, 4(5):231-244.
37. Klerman G.L. Diagnosis of psychiatric disorders in epidemiologic field studies. Archives of General Psychiatry 1985, 42(7):723-724.
38. Lehman W.E., Simpson D.D. Employee substance use and on-the-job behaviors. Journal of Applied Psychology 1992, 77(3):309-321.
39. Lev-Ran S., Imtiaz S., Taylor B.J., Shield K.D., Rehm J., Le Foll B. Gender differences in health-related quality of life among cannabis users: results from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence 2011, 123(1-3):190-200.
40. Lynskey M.T., Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000, 95(11):1621-1630.
41. Lynskey M.T., Heath A.C., Bucholz K.K., Slutske W.S., Madden P.A., Nelson E.C., et al. Escalation of drug use in early-onset cannabis users vs co-twin controls. Journal of the American Medical Association 2003, 289(4):427-433.
42. Lynskey M.T., Heath A.C., Nelson E.C., Bucholz K.K., Madden P.A., Slutske W.S., et al. Genetic and environmental contributions to cannabis dependence in a national young adult twin sample. Psychological Medicine 2002, 32(2):195-207.
43. Madras B.K., Compton W.M., Avula D., Stegbauer T., Stein J.B., Clark H.W. Screening, brief interventions, referral to treatment (SBIRT) for illicit drug and alcohol use at multiple healthcare sites: comparison at intake and 6 months later. Drug and Alcohol Dependence 2009, 99(1-3):280-295.
44. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
45. Muntoni A.L., Pillolla G., Melis M., Perra S., Gessa G.L., Pistis M. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. European Journal of Neuroscience 2006, 23(9):2385-2394.
46. Nemeroff C.B. Comorbidity of mood and anxiety disorders: the rule, not the exception?. American Journal of Psychiatry 2002, 159(1):3-4.
47. Newcomb M.D., Bentler P.M. Impact of adolescent drug use and social support on problems of young adults: a longitudinal study. Journal of Abnormal Psychology 1988, 97(1):64-75.
48. Patton G.C., Coffey C., Carlin J.B., Degenhardt L., Lynskey M., Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002, 325(7374):1195-1198.
49. Pertwee R.G. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. British Journal of Pharmacology 2008, 153(2):199-215.
50. Pull C.B., Saunders J.B., Mavreas V., Cottler L.B., Grant B.F., Hasin D.S., et al. Concordance between ICD-10 alcohol and drug use disorder criteria and diagnoses as measured by the AUDADIS-ADR, CIDI and SCAN: results of a cross-national study. Drug and Alcohol Dependence 1997, 47(3):207-216.
51. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. Journal of the American Medical Association 1990, 264(19):2511-2518.
52. Regier D.A., Kaelber C.T., Rae D.S., Farmer M.E., Knauper B., Kessler R.C., et al. Limitations of diagnostic criteria and assessment instruments for mental disorders. Implications for research and policy. Archives of General Psychiatry 1998, 55(2):109-115.
53. Reilly D., Didcott P., Swift W., Hall W. Long-term cannabis use: characteristics of users in an Australian rural area. Addiction 1998, 93(6):837-846.
54. Research Triangle Institute Software for Survey Data Analysis (SUDAAN) (Version 10) 2004, Research Triangle Institute, Research Triangle Park, NC.
55. Ruan W.J., Goldstein R.B., Chou S.P., Smith S.M., Saha T.D., Pickering R.P., et al. The alcohol use disorder and associated disabilities interview schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug and Alcohol Dependence 2008, 92(1-3):27-36.
56. Schmidt L., Weisner C., Wiley J. Substance abuse and the course of welfare dependency. American Journal of Public Health 1998, 88(11):1616-1622.
57. Strike C.J., Urbanoski K.A., Rush B.R. Who seeks treatment for cannabis-related problems?. Canadian Journal of Public Health. Revue Canadienne de Sante Publique 2003, 94(5):351-354.
58. Swift W., Coffey C., Carlin J.B., Degenhardt L., Patton G.C. Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction 2008, 103(8):1361-1370.
59. Swift W., Coffey C., Degenhardt L., Carlin J.B., Romaniuk H., Patton G.C. Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study. Journal of Epidemiology and Community Health 2011, 66(7):e26.
60. Timberlake D.S., Haberstick B.C., Hopfer C.J., Bricker J., Sakai J.T., Lessem J.M., et al. Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents. Drug and Alcohol Dependence 2007, 88(2-3):272-281.
61. Vojta C., Kinosian B., Glick H., Altshuler L., Bauer M.S. Self-reported quality of life across mood states in bipolar disorder. Comprehensive Psychiatry 2001, 42(3):190-195.
62. Vrasti R., Grant B.F., Chatterji S., Ustun B.T., Mager D., Olteanu I., et al. Reliability of the Romanian version of the alcohol module of the WHO Alcohol Use Disorder and Associated Disabilities: Interview Schedule - Alcohol/Drug-Revised. European Addiction Research 1998, 4(4):144-149.
63. Ware J., Kosinski M., Keller S.D. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 1996, 34(3):220-233.
64. Ware J., Kosinski M., Turner-Bowker D.M., Sundaram M., Gandek B., Maruish M.E. User's manual for the SF-12v2 Health Survey 2009, QualityMetric, Inc., Lincoln, RI. 2nd ed.
65. Windle M., Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Development and Psychopathology 2004, 16(4):1007-1027.
66. Zivin K., McCarthy J.F., McCammon R.J., Valenstein M., Post E.P., Welsh D.E., et al. Health-related quality of life and utilities among patients with depression in the Department of Veterans Affairs. Psychiatric Services 2008, 59(11):1331-1334.